Back to Search Start Over

Insomnia episodes, new-onset pharmacological treatments, and other sleep disturbances during the COVID-19 pandemic : a nationwide cross-sectional study in Brazilian health care professionals

Authors :
Drager, Luciano F.
Pachito, Daniela V.
Moreno, Claudia R. C.
Tavares, Almir R.
Conway, Silvia G.
Assis, Márcia
Sguillar, Danilo A.
Moreira, Gustavo A.
Bacelar, Andrea
Genta, Pedro R.
Drager, Luciano F.
Pachito, Daniela V.
Moreno, Claudia R. C.
Tavares, Almir R.
Conway, Silvia G.
Assis, Márcia
Sguillar, Danilo A.
Moreira, Gustavo A.
Bacelar, Andrea
Genta, Pedro R.
Publication Year :
2022

Abstract

Study Objectives: To evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on insomnia and other sleep disturbances in health care professionals. Methods: A survey was distributed using social media and organizational emails to Brazilian active health care professionals during the COVID-19 outbreak. We explored potential associated factors including age, sex, occupation, workplace, work hours, income, previous infection with COVID-19, recent/current contact with COVID-19 patients, regional number of incident deaths, anxiety, and burnout. We evaluated new-onset/previous insomnia worsening episodes (primary outcome), new pharmacological treatments, sleep quality, duration, nightmares, and snoring (secondary outcomes). Results: A total of 4,384 health professionals from all regions of the country were included in the analysis (44 ± 12 years, 76% females, 53.8% physicians). Overall, 55.7% were assisting patients with COVID-19, and 9.2% had a previous COVID-19 infection. The primary outcome occurred in 32.9% of respondents inparallel to 13% new pharmacological treatments for insomnia. The sleep quality worsened for 61.4%, while 43.5% and 22.8% reported≥1-hour sleep duration reduction and worsening or new-onset nightmares, respectively. Multivariate analyses showed that age (odds ratio [OR]: 1.008; 95% confidence interval [CI] 1.001–1.015), females (OR: 1.590; 95% CI 1.335–1.900), weight change (decrease: OR: 1.772; 95% CI 1.453–2.161; increase: OR: 1.468; 95% CI 1.249–1.728), prevalent anxiety (OR: 3.414; 95% CI 2.954–3.948), new-onset burnout (OR: 1.761; 95% CI 1.489–2.083), family income reduction > 30% (OR: 1.288; 95% CI 1.069–1.553), and assisting patients with COVID-19 (OR: 1.275; 95% CI 1.081–1.506) were independently associated with new-onset or worsening of previous insomnia episodes. Conclusions: We observed a huge burden of insomnia episodes and other sleep disturbances in health care professionals during the COVID-19 pandemic.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1356420159
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.5664.jcsm.9570